Find Funding Opportunities

 COVID-19 Funding Notices | Approved Initiative Concepts | Research Opportunity Announcements

All NINDS-related notices of funding opportunities (NOFOs), request for applications (RFAs), program announcements (PAs), and other NIH Guide announcements are listed. Search the Closed Opportunities tab to find expired opportunities. Search the Notices tab to find all Notices.

Learn more about award types and program directors and managers.

NINDS has a number of open positions for researchers and clinicians to contribute to exciting neuroscience programs - APPLY NOW!

For more focused results add quotes to indicate parameters. Example format: "search term".

Expiration Date: Friday, January 1, 2027 NOFO Number: NOT-NS-15-003 Release Date: Monday, December 8, 2014 Notice Type: NOT
Notice Correction Regarding Companion Funding Opportunity Information PAR-14-286 quot;NINDS CREATE Bio Discovery Track: Optimization Preparation Development Biotechnology Products Biologics U01)" Notice Number: NOT-NS-15-003 Key Dates Release Date: December 8, 2014 Related Announcements PAR-14-286 Issued National Institute Neurological Disorders Stroke NINDS) Purpose Notice clarifies information regarding companion funding opportunities PAR-14-286 quot;NINDS CREATE Bio Discovery Track: Optimization Preparation Development Biotechnology Products Biologics U01)". Part 1. Overview Information FOA currently reads: Companion Funding Opportunity PAR-14-288, UH2/UH3 Phase Innovation Awards Cooperative Agreement PAR-14-287, U44 Small Business Innovation Research SBIR) Cooperative Agreement ndash; Fast-Track PAR-14-289, U44 Small Business Innovation Research SBIR) Cooperative Agreement ndash; Fast-Track FOA modified read: Companion Funding Opportunity PAR-14-288, UH2/UH3 Phase Innovation Awards Cooperative Agreement PAR-14-287, U44 Small Business Innovation Research SBIR) Cooperative Agreement ndash; Phase II, Fast-Track PAR-14-289, U44 Small Business Innovation Research SBIR) Cooperative Agreement ndash; Fast-Track other aspects the FOA remain unchanged. Inquiries Please direct inquiries to: Hao Wang, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1779 Email: CREATEinquiries@mail.nih.gov
Expiration Date: Friday, January 1, 2027 NOFO Number: NOT-NS-15-006 Release Date: Monday, December 8, 2014 Notice Type: NOT
Notice Correction Regarding Companion Funding Opportunity Information PAR-14-289 quot;NINDS CREATE Bio Development Track: Preclinical Early-phase Clinical Development Biotechnology Products Biologics U44)" Notice Number: NOT-NS-15-006 Key Dates Release Date: December 8, 2014 Related Announcements PAR-14-289 Issued National Institute Neurological Disorders Stroke NINDS)) Purpose Notice clarifies information regarding companion funding opportunities PAR-14-289 quot;NINDS CREATE Bio Development Track: Preclinical Early-phase Clinical Development Biotechnology Products Biologics U44)". Part 1. Overview Information FOA currently reads: Companion Funding Opportunity PAR-14-288, UH2/UH3) Exploratory/Developmental Cooperative Agreement Phase I/ Phase II PAR-14-286, U01) Research Projects - Cooperative Agreements PAR-14-287, U44) Small Business Innovation Research SBIR) Cooperative Agreement ndash; Fast-track only FOA modified read: Companion Funding Opportunity PAR-14-288, UH2/UH3) Exploratory/Developmental Cooperative Agreement Phase I/ Phase II PAR-14-286, U01) Research Projects - Cooperative Agreements PAR-14-287, U44) Small Business Innovation Research SBIR) Cooperative Agreement ndash; Phase II, Fast-Track other aspects the FOA remain unchanged. Inquiries Please direct inquiries to: Hao Wang, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1779 Email: CREATEinquiries@mail.nih.gov
Expiration Date: Friday, January 1, 2027 NOFO Number: NOT-NS-15-004 Release Date: Monday, December 8, 2014 Notice Type: NOT
Notice Correction Regarding Application Types Allowed PAR-14-287 quot;NINDS CREATE Bio Discovery Track: Optimization Preparation Development Biotechnology Products Biologics U44)" Notice Number: NOT-NS-15-004 Key Dates Release Date: December 8, 2014 Related Announcements PAR-14-287 Issued National Institute Neurological Disorders Stroke NINDS) Purpose Notice clarifies application types allowed PAR-14-287. Part 2. Section II. Award Information FOA currently reads: Application Types Allowed New Fast-Track) Renewal Fast-Track) Resubmission Fast-Track) Revision Fast-Track) FOA modified read: Application Types Allowed New Fast-Track) Renewal Phase II) Resubmission Fast-Track Phase II) Revision Fast-Track Phase II) other aspects the FOA remain unchanged. Inquiries Please direct inquiries to: Hao Wang, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1779 Email: CREATEinquiries@mail.nih.gov
Expiration Date: Friday, January 1, 2027 NOFO Number: NOT-EB-14-008 Release Date: Thursday, October 23, 2014 Notice Type: NOT
Notice Updates the National Robotics Initiative NRI) Notice Number: NOT-EB-14-008 Key Dates Release Date:   October 23, 2014 Related Announcements NOT-EB-15-008 NOT-EB-13-005 Issued National Institutes Health NIH) National Eye Institute NEI) National Institute Aging NIA) National Institute Biomedical Imaging Bioengineering NIBIB) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Deafness Other Communication Disorders NIDCD) National Institute Neurological Disorders Stroke NINDS) National Institute Nursing Research NINR) Office Behavioral Social Sciences Research OBSSR) National Science Foundation NSF) National Aeronautics Space Administration NASA) U.S. Department Agriculture USDA) Defense Advanced Research Projects Agency DARPA) Purpose Notice updates supersedes previous Guide Notice, NOT-EB-13-005, published the NIH Guide, October 29, 2013. NIH collaborating a multi-agency funding opportunity, National Robotics Initiative NRI) http://www.nsf.gov/funding//pgm_summ.jsp?pims_id=503641), whose goal to accelerate development use robots the United States work beside, cooperatively with, people http://www.nsf.gov/pubs/2015/nsf15505/nsf15505.htm).  Innovative robotics research applications emphasizing realization such co-robots working symbiotic relationships human partners supported multiple agencies the federal government including National Science Foundation NSF), National Aeronautics Space Administration NASA), National Institutes Health NIH), U.S. Department Agriculture USDA), the U.S. Department Defense DOD). purpose this program the development this next generation robotics, advance capability usability such systems artifacts, to encourage existing new communities focus innovative application areas. will address entire life cycle fundamental research development manufacturing deployment. Collaboration between academic, industry, non-profit other organizations strongly encouraged establish better linkages between fundamental science technology development, deployment use. NIH encourages robotics research technology development enhance health, lengthen life reduce illness disability. NIH also supports non-hypothesis driven applications, includes technology-driven problem-driven applications. Specifically, participating NIH Institutes Centers ICs) this solicitation interested targeting solicitation support development assistive robotic technology achieve functional independence humans; improve quality life; assist behavioral therapy personalized care; promote wellness/health. most significant challenges be addressing safety issues, especially applications be used home-based long-term care settings where integration complex systems be required. Additionally, assistive robots need quickly adapt changes the user the environment. Human assistive devices should designed assist healthcare providers as well the individuals needing care. Development robotic applications important NIH because their potential significant impact healthcare the future. Human assistive devices revolutionize healthcare the next 20 years much personal electronics changed our daily lives the past decades. Affordable accessible robotic technology facilitate wellness personalized healthcare. Continual health assessment personalized intervention the potential offset shrinking size the healthcare workforce the growing elderly disabled population. the future, assistive robotics enable people engage all aspects human life endurance dignity. Examples assistive robotic technology development include are limited to: - Homecare long-term personalized care robots - Robotic wellness/health promotion maintenance - Robotic behavioral therapy - Robotic aids mobility, manipulation, human communication cognition, vision non-sighted persons - Assistive robotics eliminate health disparities across populations developing appropriate assistive co-robotic technologies, applicants should consider following basic characteristics: effectiveness, affordability, cultural acceptability, accessibility those need them.  Applicants should describe these technologies address healthcare needs the end user healthy individuals, persons disability, or health disparity populations). robotic applications promoted this solicitation for non-operative settings.  NIH still interested supporting robotics surgical health interventions robotic exoskeletons, however, in response solicitation.  Applicants interested this area should send inquiries the NIH contacts listed below.  Award Information Award sizes NIH funded research projects expected range approximately 100,000 250,000 per year direct costs, durations one three years.  award exceed 250,000 per year direct costs. Applicants wish submit proposal NIH more 250,000 direct costs any grant should contact Program staff an NIH Institute/Center directly alternate proposal mechanisms.  Estimated program budget, number awards average award size duration subject the availability funds.  Determination awards based three criteria: 1) availability funds, 2) program priorities, 3) scientific merit. Subsequent grant administration procedures be accordance the policies the awarding Institute. Application Preparation Submission Instructions Applications submitted response this solicitation should prepared submitted accordance the general guidelines contained the NSF Grant Proposal Guide GPG).  Applications must submitted the NSF, to NIH.  complete text the GPG available electronically the NSF website http://www.nsf.gov/publications/pub_summ.jsp?ods_key=gpg. Applicants reminded identify NSF program announcement number the program announcement block the NSF Cover Sheet Proposal the National Science Foundation.  Compliance this announcement critical determining relevant application processing guidelines.  Failure submit information delay processing. Budgetary Information Cost sharing not required applications submitted this funding opportunity. Budgets should include travel funds the PD/PI team members attend annual NRI Principal Investigators' meeting. NIH Process goal this activity to involve multiple agencies using application one review. meet NIH requirements, those applications are identified potential funding participating NIH ICs, applicant organization be required submit R01 application an NIH-approved format.  PD/PIs invited submit NIH receive further information submission procedures the NIH. NIH application not allowed increase proposed budget change scientific content the application the converted submission the NIH. The summary statement be presented the involved IC's National Advisory Council the second level review. Subsequent the Council review, NIH ICs make funding determinations selected awards be made. Grant administration procedures NIH awardees, including those related New Early Stage Investigators http://grants.nih.gov/grants/new_investigators/) be accordance the policies NIH. Please note applications be submitted review the NSF January 14, 2015. PDs/PIs applications selected potential funding the participating NIH ICs be notified the end March 2015.  converted submission NIH be due April 7, 2015, will an extremely short conversion time.  applicant organization want work closely their Sponsored Programs Office assure timely submission during narrow submission window. earliest project start date be July 1, 2015. Inquiries Written telephone inquiries encouraged.  NIH Program contacts listed below. Please the NSF NRI website names contact information each the participating NSF Directorates, USDA, NASA DARPA http://www.nsf.gov/nri.   Grace C.Y. Peng, Ph.D., National Institute Biomedical Imaging Bioengineering NIBIB) Telephone: 301-451-4778;  Email: penggr@mail.nih.gov   Tom Greenwell, Ph.D. National Eye Institute NEI) Telephone: 301-451-2020 Email:  greenwellt@nei.nih.gov Lyndon Joseph, Ph.D National Institute Aging NIA) Telephone: 301-496-6926 Email: Josephlj@nia.nih.gov          Louis Quatrano, Ph. D. Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) Telephone:  301-402-4221 Email: quatranl@mail.nih.gov Roger L. Miller, Ph.D. National Institute Deafness Other Communication Disorders NIDCD) Telephone: 301-402-3458 Email:  millerr@nidcd.nih.gov Daofen Chen, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-9964 Email: daofen.chen@nih.gov Augie Diana, Ph.D. National Institute Nursing Research NINR) Telephone: 301-402-6423 Email: dianaa@mail.nih.gov Wendy J. Nilsen, Ph.D. Office Behavioral Social Sciences Research OBSSR) Telephone:  301-496-0979 Email: nilsenwj@od.nih.gov
Expiration Date: Friday, January 1, 2027 NOFO Number: NOT-NS-15-001 Release Date: Wednesday, October 22, 2014 Notice Type: NOT
Notice Correction Regarding Institution Eligibility Requirements RFA-NS-14-013 quot;NINDS Institutional Center Core Grants Support Neuroscience Research P30)" Notice Number: NOT-NS-15-001 Key Dates Release Date: nbsp;October 22, 2014 Related Announcements RFA-NS-14-013 Issued National Institute Neurological Disorders Stroke NINDS)  Purpose Notice clarifies number P30 grants allowed per Institution provides supplemental instructions Section III.3 quot;Additional Information Eligibility" RFA-NS-14-013. Part 2. Section III. Eligibility Information 3. Additional Information Eligibility Currently reads: Number Applications Only application per institution normally identified having unique DUNS number NIH IPF number) allowed. Modified read: Number Applications: Only application per institution normally identified having unique DUNS number NIH IPF number) allowed.  Additionally, institution eligible a maximum one NINDS Center Core Grant. other aspects this FOA remain unchanged. Inquiries Please direct inquiries to: Edmund Talley, Ph.D. National Institute Neurological Disorders Stroke NINDS)  Telephone: 301-496-1917 Email: TalleyE@mail.nih.gov
Expiration Date: Friday, January 1, 2027 NOFO Number: NOT-NS-14-051 Release Date: Friday, October 10, 2014 Notice Type: NOT
Notice Intent Publish Funding Opportunity Announcement The NINDS Human Biomarkers Biospecimen Repository U2C) Notice Number: NOT-NS-14-051 Key Dates Release Date: October 10, 2014 Estimated Publication Date Announcement: January 2015  First Estimated Application Due Date: March 2015   Earliest Estimated Award Date: October 2015  Earliest Estimated Start Date: October 2015  Related Announcements None Issued National Institute Neurological Disorders Stroke NINDS) Purpose National Institute Neurological Disorders Stroke NINDS) intends promote new initiative publishing Funding Opportunity Announcement FOA) solicit applications biospecimen banking associated data management biomarkers neurological disorders. Notice intended allow potential applicants sufficient time develop meaningful collaborations responsive projects. FOA expected be published early 2015 an expected application due date late spring/early summer 2015. FOA utilize U2C activity code. Details the planned FOA provided below. Research Initiative Details Notice encourages investigators expertise biomarkers biospecimen handling data management begin consider applying this new FOA. Collaborative investigations combining expertise data management biospecimen handling be encouraged. Applicants should expertise biospecimen laboratory processes, banking, data management. Experience biomarker research, such evaluation batch effects, protocol development, analyte quality control measures, expected. APPLICATIONS NOT BEING SOLICITED THIS TIME. Inquiries Please direct inquiries to: Katrina Gwinn, MD National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-5745 Email: gwinnk@ninds.nih.gov
Expiration Date: Friday, January 1, 2027 NOFO Number: NOT-NS-14-054 Release Date: Friday, September 26, 2014 Notice Type: NOT
Request Information RFI):  B.R.A.I.N. Initiative Public/Private Partnership Accelerate Clinical Access Next-Generation Stimulating/Recording Devices Notice Number: NOT-NS-14-054 Key Dates Release Date: September 26, 2014 Response Date: November 21, 2014 nbsp;  Related Announcements None Issued National Institute Neurological Disorders Stroke NINDS) National Eye Institute NEI) National Institute Aging NIA) National Institute Alcohol Abuse Alcoholism NIAAA) National Institute Biomedical Imaging Bioengineering NIBIB) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Drug Abuse NIDA) National Institute Deafness Other Communication Disorders NIDCD) National Institute Mental Health NIMH) National Center Complementary Alternative Medicine NCCAM) Purpose Brain Research through Advancing Innovative Neurotechnologies BRAIN) Working Group recommended new quot;streamlined path developing, implementing integrating new technologies human neuroscience research, through cooperation clinical academic research teams private companies a pre-competitive space" their landmark report the Advisory Committee the National Institutes Health NIH) Director titled quot;BRAIN 2025: Scientific Vision".  Towards end, NIH interested developing public/private partnerships manufacturers novel significant risk' stimulating and/or recording devices facilitate broad access these devices conduct clinical research. Investigational Device Exemptions IDE) regulation 21 CFR 812) describes three types devices studies: significant risk SR), non-significant risk NSR), exempt studies. Clinical research utilizing SR devices a new indication to answer scientific questions require Investigational Device Exemption IDE) the FDA. Moreover, devices available sale often expanded research capabilities could used accelerate additional clinical research studies, enabling those features require new IDE ensure appropriate in controlled research setting. Due the complexity the manufacturing requirements the statutory requirements market medical devices the U.S., may a period time between initial first-in-human demonstrations a novel technology the market approval clearance required legally market device widespread use.  Although first-in-human studies be sufficient demonstrate safety utility the technology answer clinical research questions a highly controlled environment, additional time before market approval clearance primarily needed conduct Feasibility Pivotal trial demonstrate safety effectiveness a device a specific intended use, typically a statistically justified number subjects.  studies also necessary further understand potential safety risks implanted scale under typical usage conditions adequately evaluate benefit/risk profile the device.      nbsp;  NIH recognizes opportunity work leading academics, clinical researchers, industry the FDA develop streamlined path provide clinical researchers widespread access next-generation technologies have already demonstrated safety Early Feasibility/Proof-of-Concept clinical studies, well enabling capability answer impactful research questions.  particular, NIH interested identifying manufacturers willing share pre-clinical safety technical data support new IDEs clinical research these devices.  is anticipated enabled studies include fundamental human neuroscience research, studies better understand mechanisms action existing therapies, well exploratory studies demonstrate therapeutic potential these existing devices small market indications.        purpose this time-sensitive RFI, issued the Institutes the NIH BRAIN Initiative http://www.nih.gov/science/brain/funding.htm), to seek input interested academic/clinical researchers, regulatory other government agencies, potential industry partners identify key barriers potential opportunities grant earlier broad access significant risk recording and/or stimulating medical devices clinical research.  the intent to address unique manufacturing regulatory burden SR implantable medical devices, scope the RFI limited invasive technologies can stimulate and/or record the brain, for first IDEs already obtained could obtained the very near term.  RFI intended gather relevant information identify interested parties inform follow-on workshop.  RFI workshop lead a subsequent funding opportunity announcement FOA); however, RFI should be construed a funding opportunity. Information Requested NIH invites input stakeholders including not limited researchers academia industry, healthcare professionals, patient advocates advocacy organizations, scientific professional organizations, federal agencies other interested members the public.  Small businesses appropriate technologies especially encouraged provide input.  NIH interested human neuroscience research, novel therapeutic approaches, further understanding the mechanisms action existing therapies, well interdisciplinary approaches span areas. input include is limited the following topics: New and/or ongoing challenges opportunities conducting clinical research utilizing significant risk medical devices either pre-market approval, using expanded research platforms existing market approved devices) Opportunities concerns utilizing public/private partnership structure including intellectual property, common data standards access annotation Extent industry contribution, potentially include free devices technical support, access pre-clinical data support new IDEs, cost-sharing, construction maintenance publically accessible data repositories Additional sources data could obtained supplement limited opportunities available utilize invasive recording/stimulating devices maximize value these studies the wider community to Submit Response ensure consideration, responses must received November 21, 2014, must submitted electronically using web-based format http://braininitiative.nih.gov/rfi-brain-initiative.htm. web format provide confirmation response submission, respondents not receive individualized feedback. Responses this RFI voluntary may submitted anonymously. Please not include any personally identifiable other information you not wish make public. Proprietary, classified, confidential sensitive information should be included your response. Comments be compiled discussion may appear related reports. Any personal identifiers names, e-mail addresses, etc.) be removed responses compiled. RFI for informational planning purposes only should be construed a solicitation as obligation the part the United States US) Government, NIH the NINDS provide support any ideas submitted response it. Please note the US Government, NIH NINDS not pay the preparation any information submitted, for use that information. Inquiries Please direct inquiries to: Kip Ludwig, PhD National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1447 Email: kip.ludwig@nih.gov
Expiration Date: Friday, January 1, 2027 NOFO Number: NOT-NS-14-053 Release Date: Thursday, September 25, 2014 Notice Type: NOT
Notice Intent Publish Funding Opportunity Announcement NINDS Morris K. Udall Centers Excellence Parkinson's Disease Research P50) Notice Number: NOT-NS-14-053 Key Dates Release Date: nbsp;September 25, 2014 Estimated Publication Date Announcement: nbsp;November 2014  First Estimated Application Due Date: nbsp;January 2015 Earliest Estimated Award Date: nbsp;July 2015  Earliest Estimated Start Date: nbsp;July 2015  Related Announcements None Issued National Institute Neurological Disorders Stroke NINDS) Purpose National Institute Neurological Disorders Stroke NINDS) continue Morris K. Udall Centers Excellence Parkinson's Disease Research program publishing Funding Opportunity Announcement FOA) new renewal applications. purpose this Notice to alert potential applicants to provide sufficient lead time the development responsive projects. FOA utilize Specialized Center P50) activity code, will support spectrum basic, translational clinical research activities utilizing integrated, multidisciplinary approach a specific disease entity, Parkinson's Disease PD). is anticipated this FOA be published autumn 2014 an expected application due date winter 2015. Research Initiative Details NINDS intends solicit new renewal applications the Morris K. Udall Centers Excellence Parkinson’s Disease Research program, consortium specialized Centers work collaboratively well independently define causes and discover improved treatments this disease. Individual Centers establish unique, interdisciplinary programs optimize available expertise basic, translational clinical research required advance PD research. overall theme, proposed research projects integral cores each Center relate directly the etiology, pathogenesis treatment PD. considerable degree collaboration among investigators required achieve overarching objectives each Center. application must address relevance the research recommendations the NINDS conference quot;Parkinson's Disease 2014: Advancing Research, Improving Lives." Notably, Centers Excellence, Udall Centers serve regional national resources PD research. Successful applicants participate the network existing Udall Centers foster translation scientific findings novel treatments PD. Applicants request maximum annual direct costs 1,500,000. APPLICATIONS NOT BEING SOLICITED THIS TIME. Inquiries Please direct inquiries to: Beth-Anne Sieber, PhD National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-5680 Email: sieberb@ninds.nih.gov
Expiration Date: Friday, January 1, 2027 NOFO Number: NOT-NS-14-052 Release Date: Thursday, September 25, 2014 Notice Type: NOT
Notice Intent Publish Funding Opportunity Announcement The NINDS Human Cell Resource Repository U42) Notice Number: NOT-NS-14-052 Key Dates Release Date:   September 25, 2014 Estimated Publication Date Announcement: January 2015   First Estimated Application Due Date: March 2015       Earliest Estimated Award Date: October 2015      Earliest Estimated Start Date: October 2015      Related Announcements None Issued National Institute Neurological Disorders Stroke NINDS) Purpose National Institute Neurological Disorders Stroke NINDS) intends promote new initiative publishing Funding Opportunity Announcement FOA) solicit applications will support development a human cell resource repository focused derivation, standardized quality assessment, biobanking, data management distribution human iPSC fibroblast lines identified unique high value resources the neuroscience community for study neurological disorders Notice being provided allow potential applicants sufficient time develop meaningful collaborations responsive projects.  FOA expected be published the winter 2015 an expected application due date spring 2015.   FOA utilize U42 activity code. Details the planned FOA provided below. Research Initiative Details Notice encourages investigators expertise insights the areas human iPSC derivation multiple human biospecimen sources including not limited fibroblasts peripheral blood mononucleated cells PBMCs), fibroblast derivation skin biopsies, iPSC genomic modification/editing, biobanking begin consider applying this new FOA. addition, collaborative investigations combining expertise iPSC derivation data patent/ licensing management around technologies related iPSC derivation genome editing be encouraged these investigators should also begin consider applying this application. Among areas research encouraged this initiative stem cell biology, biobanking, data management, genome editing, quality assessment standards iPSC fibroblasts lines, community outreach.  Knowledge application new technologies iPSC line generation, modification quality assessment contribute best practice paradigms this rapidly evolving field encouraged. APPLICATIONS NOT BEING SOLICITED THIS TIME. Inquiries Please direct inquiries to: Margaret Sutherland, PhD National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-5680 Email: sutherlandm@ninds.nih.gov
Expiration Date: Friday, January 1, 2027 NOFO Number: NOT-NS-14-050 Release Date: Thursday, September 18, 2014 Notice Type: NOT
Notice Extend Expiration Date PAR-12-073 quot;NINDS Exploratory Clinical Trials Small Business SBIR R44])" Notice Number: NOT-NS-14-050 Key Dates Release Date: September 18, 2014 nbsp; Related Announcements PAR-12-073 Issued National Institute Neurological Disorders Stroke NINDS) nbsp;  Purpose Notice extends expiration date PAR-12-073 quot;NINDS Exploratory Clinical Trials Small Business SBIR R44])", one funding cycle. Current Expiration Date: January 8, 2015 New Expiration Date: 8, 2015 Inquiries Please direct inquiries to: Stephanie Fertig National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1779 Email: fertigs@ninds.nih.gov
Export to:
A maximum of 400 records can be exported.